Sommaire

• • ·Dual randomization in cardiovascular trials

    Page :1

    Robert M. Califf

    
• • ·Is the emperor really wearing new clothes? Informed consent for acute coronary syndromes

    Page :2-3

    Jeremy Sugarman

    
• • ·Clinical evaluation of chelation therapy: Is there any wheat amidst the chaff?

    Page :4-5

    Gervasio A. Lamas, Alan Ackermann

    
• • ·Atorvastatin Versus Revascularization Treatment (AVERT): Fact or fancy?

    Page :6-9

    Balkrishna M. Singh, Sanjeev Puri, Jorge Saucedo, J.David Talley

    
• • ·Should we revise our diagnostic methods for Q-wave myocardial infarction in the presence of right bundle branch block?

    Page :10-11

    Ihor Gussak, R.Scott Wright, Stephen L. Kopecky

    
• • ·Classification and pharmacology of antiarrhythmic drugs

    Page :12-20

    Peter R. Kowey, Roger A. Marinchak, Seth J. Rials, David B. Bharucha

    Résumé Résumé
• • ·Chronic heart failure and exercise

    Page :21-28

    Peter F Kokkinos, Wassim Choucair, Page Graves, Vasilios Papademetriou, Samer Ellahham

    
• • ·Hierarchy of risk based on history and location of prior myocardial infarction in the thrombolytic era

    Page :29-33

    David B Brieger, Koon-Hou Mak, David P Miller, Robert M Califf, Eric J Topol

    Résumé Résumé
• • ·Dissociation between ACE activity and autonomic response to ACE inhibition in patients with heart failure

    Page :34-42

    Philip F. Binkley, Enrico Nunziata, Garrie J. Haas, Randall C. Starling, Carl V. Leier, Robert J. Cody

    Résumé Résumé
• • ·Arrhythmia risk stratification in idiopathic dilated cardiomyopathy based on echocardiography and 12-lead, signal-averaged, and 24-hour Holter electrocardiography

    Page :43-51

    Wolfram Grimm, Christina Glaveris, Jürgen Hoffmann, Volker Menz, Hans-Helge Müller, Günther Hufnagel, Bernhard Maisch

    Résumé Résumé
• • ·Exercise-induced ST-segment depression and systolic dysfunction in patients with nonobstructive hypertrophic cardiomyopathy

    Page :52-60

    Masami Shimizu, Hidekazu Ino, Kazuyasu Okeie, Yorito Emoto, Masato Yamaguchi, Toshihiko Yasuda, Noboru Fujino, Hiroyuki Fujii, Shinichiro Fujita, Tomohito Mabuchi, Junichi Taki, Hiroshi Mabuchi

    Résumé Résumé
• • ·Infarct size determination by technetium 99m sestamibi single-photon emission computed tomography predicts survival in patients with chronic coronary artery disease

    Page :61-66

    David G. Hurrell, James Milavetz, David O. Hodge, Raymond J. Gibbons

    Résumé Résumé
• • ·Reduction in the need for hospitalization for recurrent ischemic events and bleeding with clopidogrel instead of aspirin

    Page :67-73

    Deepak L. Bhatt, Alan T. Hirsch, Peter A. Ringleb, Werner Hacke, Eric J. Topol

    Résumé Résumé
• • ·Clinical correlates and course of thrombocytopenia during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade

    Page :74-80

    Dean J. Kereiakes, Scott D. Berkowitz, A.Michael Lincoff, James E. Tcheng, Kathy Wolski, Rob Achenbach, Richard Melsheimer, Keaven Anderson, Robert M. Califf, Eric J. Topol

    Résumé Résumé
• • ·First report of an intravenous and oral glycoprotein IIb/IIIa inhibitor (RPR 109891) in patients with recent acute coronary syndromes: Results of the TIMI 15A and 15B trials

    Page :81-93

    Robert P. Giugliano, Carolyn H. McCabe, Rafael F. Sequeira, Martin J. Frey, Timothy D. Henry, Robert N. Piana, Jean-Francois Tamby, Bradford K. Jensen, Sylvain B. Nicolas, Lisa K. Jennings, Robert J. Wise, Eugene Braunwald

    Résumé Résumé
• • ·Is informed consent to clinical trials an “upside selective” process in acute coronary syndromes?

    Page :94-97

    Angela Marie Kucia, John David Horowitz

    Résumé Résumé
• • ·Association of age, sex, and race with body iron stores in adults: Analysis of NHANES III data

    Page :98-104

    Leo R. Zacharski, Deborah L. Ornstein, Steven Woloshin, Lisa M. Schwartz

    Résumé Résumé
• • ·Association between depression and worse disease-specific functional status in outpatients with coronary artery disease

    Page :105-110

    John A. Spertus, Mary McDonell, Catherine L. Woodman, Stephan D. Fihn

    Résumé Résumé
• • ·Heart diseases affecting the liver and liver diseases affecting the heart

    Page :111-120

    Jochanan E. Naschitz, Gleb Slobodin, Roger J. Lewis, Elimelech Zuckerman, Daniel Yeshurun

    Résumé Résumé
• • ·Collateral recruitment and “warm-up” after first exercise in ischemic heart disease

    Page :121-125

    I.Patrick Kay, John Kittelson, Ralph A.H. Stewart

    Résumé Résumé
• • ·Prodromal unstable angina in acute myocardial infarction: Prognostic value of short- and long-term outcome and predictor of infarct size

    Page :126-133

    Raymond D. Bahr, E.Victor Leino, Robert H. Christenson

    Résumé Résumé
• • ·Histopathologic and clinical characterization of cardiac myxoma: Review of 53 cases from a single institution

    Page :134-138

    Angela Pucci, Piervincenzo Gagliardotto, Cristina Zanini, Stefano Pansini, Michele di Summa, Franco Mollo

    Résumé Résumé
• • ·Chelation therapy for coronary heart disease: An overview of all clinical investigations

    Page :139-141

    E. Ernst

    Résumé Résumé
• • ·Observations on the transition from intermittent to permanent atrial fibrillation

    Page :142-145

    Sana M. Al-Khatib, William E. Wilkinson, Linda L. Sanders, Elizabeth A. McCarthy, Edward L.C. Pritchett

    Résumé Résumé
• • ·A novel mutation in KVLQT1, L122P, found in a family with autosomal dominant long QT syndrome

    Page :146-149

    Andrew D. Krahn, Jian Wang, Bonnie Spindler, Allan C. Skanes, Raymond Yee, George J. Klein, Robert A. Hegele

    Résumé Résumé
• • ·Efficacy of anticoagulation in resolving left atrial and left atrial appendage thrombi: A transesophageal echocardiographic study

    Page :150-156

    Wael A. Jaber, David L. Prior, Maran Thamilarasan, Richard A. Grimm, James D. Thomas, Allan L. Klein, Craig R. Asher

    Résumé Résumé
• • ·Effect of exercise training on heart rate variability in patients with new-onset left ventricular dysfunction after myocardial infarction

    Page :157-161

    Firat Duru, Reto Candinas, Gerald Dziekan, Ute Goebbels, Jonathan Myers, Paul Dubach

    Résumé Résumé
• • ·Race, baseline characteristics, and clinical outcomes after coronary intervention: The New Approaches in Coronary Interventions (NACI) registry

    Page :162-169

    David Scott Marks, George A. Mensah, Elizabeth D. Kennard, Katherine Detre, David R. Holmes

    Résumé Résumé
• • ·A1166C polymorphism of the angiotensin II type 1 receptor gene and risk of adverse events after coronary catheter interventions

    Page :170-175

    Karl Stangl, Ingolf Cascorbi, Verena Stangl, Michael Laule, Przemyslaw M. Mrozikiewicz, Michaela Schwarz^b, Stephan B. Felix, Heinz Theres, Gert Baumann, Ivar Roots

    Résumé Résumé
• • ·Esmolol versus diltiazem in the treatment of postoperative atrial fibrillation/atrial flutter after open heart surgery

    Page :176-180

    Aryan N. Mooss, Richard L. Wurdeman, Syed M. Mohiuddin, Antonio P. Reyes, Jeffrey T. Sugimoto, Walter Scott, Daniel E. Hilleman, Ali Seyedroudbari

    Résumé Résumé
• • ·Highlights from the American College of Cardiology 49th Annual Scientific Sessions: March 12 to 15, 2000

    Page :181-188

    Darren K. McGuire, J.Conor O’Shea, Christopher K. Dyke, David E. Kandzari, Mark A. East, Thaddeus R. Tolleson

    
• • ·Memory function in patients with stable, moderate to severe cardiac failure

    Page :E1

    Neil R. Grubb, Catriona Simpson, Keith A.A. Fox

    Résumé Résumé
• • ·Improvement of exercise capacity and left ventricular diastolic function with metoprolol XL after acute myocardial infarction

    Page :E6

    Steen Hvitfeldt Poulsen, Svend E. Jensen, Kenneth Egstrup

    Résumé Résumé
• • ·Low-molecular-weight heparin alone versus a combination of unfractionated heparin and low-molecular-weight heparin

    Page :E12

    Enrique P. Gurfinkel, Jose Santopinto, Gerardo E. Bozovich, Alberto Quispe, Alejandra Strinna, Branco Mautner

    Résumé Résumé